Highlights • MYOR’s 1H25 net profit fell 32% yoy on margin compression, although revenue remained solid, supported by stronger export growth. • Expect a seasonal recovery in 3Q25, with 2H25 domestic demand likely to be more favourable than that in 1H25, supported by expected improvements in macro conditions. • We revise 2025-26 EPS by -13.1%/-13.0% due to margin pressure from the rise in raw material prices. Maintain HOLD with Rp2,400 target price and roll over valuation to 2026 with a multiple ...
Economics | External Debt Indonesia's external debt fell to US$432.5b in Jul 25, with growth slowing to 4.1% yoy. The decline was driven by reduced government and central bank borrowings, while private sector debts contracted due to high global interest rates and domestic liquidity. This improved the nation's interest payment costs. Debt is projected to grow at a faster pace, supported by easing global interest rates and stronger domestic economic activity. Company Update | Mayora Indah (MYOR I...
Greater China Sector Update | Consumer On 16 Sep 25, the Ministry of Commerce and eight other government departments jointly issued a plan to expand service consumption. This plan introduces 19 measures focusing on five areas. We highlight IP-related consumption and tourism as the two primary themes positioned to benefit the most. In addition, the government plans to optimise student vacation schedules by exploring the possibility of shortening winter and summer vacations while introducing spri...
In Jul 25, our portfolio underperformed the JCI by -11.1%, mainly due to the rally in conglomerate-related stocks (with the largest contributors being DCII, BREN, BRPT, DSSA and CDIA). Assuming no price movement in the top 10 conglomerate-related stocks, our portfolio underperformed the JCI by -5.3%. Events to monitor next week include Indonesia’s 2Q25 GDP figure and MSCI announcements on 5 and 7 August. Our new Alpha Picks are ASSA, AKRA, ARCI, BBNI, MTEL, KLBF and MYOR.
GREATER CHINA Update Baoshan Iron & Steel (600019 CH/BUY/Rmb7.44/Target: Rmb8.20) Riding the policy wave, watching for undercurrents. Shenzhen Mindray Bio-Medical Electronics (300760 CH/BUY/Rmb231.84/Target: Rmb325.00) Regaining growth momentum from Q3 2025, on track for top 10 global medtech status. INDONESIA Sector Consumer 2Q25 preview: Mixed results. Results Bank Negara Indonesia (BBNI IJ/BUY/Rp4,090/Target: Rp5,...
Despite macroeconomic headwinds, we expect 1H25 results across the consumer sector to reflect resilient momentum in selective segments, with performance diverging by product category, pricing power, margin management and adaptability. While weak purchasing power likely weighed on mass-market demand, easing soft commodity prices may improve sentiment. We upgrade the sector to OVERWEIGHT. Top picks: KLBF, CMRY and ERAA.
Consumer: 2Q25 preview: Mixed results. Bank Negara Indonesia (BBNI IJ/BUY/Rp4,090/Target: Rp5,100): 2Q25: NIM likely to have bottomed, with recovery expected in 2H25. TRADERS’ CORNER Tower Bersama Infrastructure (TBIG IJ): Technical BUY Indofood CBP Sukses Makmur (ICBP IJ): Technical BUY
GREATER CHINA Strategy Alpha Picks: July Conviction Calls Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. Sector Online Games Upcoming new game releases to capitalise on the summer holiday season. INDONESIA Strategy Alpha Picks: Good Performances In June Our new alpha picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA...
Our Jun 25 portfolio outperformed the JCI and LQ45 by +5.1%/+7.1% respectively, mainly driven by DKFT (+16% performance) and outperformances by other stocks such as ANTM, CMRY and AMRT. Several major events to watch out this month include upcoming IPOs (especially the sizeable Chandra Daya Investasi (CDIA) IPO worth about US$143m) and the outcome of the US-Indo reciprocal tariffs discussion on 9 July. Our new Alpha Picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA, AMRT and TLKM.
GREATER CHINA Sector Automobile: Weekly: PEV sales edged up wow. Maintain MARKET WEIGHT on the sector. Top BUYs: BYD, Geely and Desay SV. Healthcare: The rising robotic surgical system market in China. Results Alibaba Group (9988 HK/BUY/HK$128.90/Target: HK$165.00): 4QFY25: Slight earnings miss; CMR delivers better-than-expected double-digit growth. Geely Auto (175 HK/BUY/HK$19.58/Target: HK$31.00): 1Q25: Earnings beat on forex gain and associate profit. Maintain BUY. Raise target price to HK$31...
We lower our 2025 net profit assumptions by 8.5% following the weaker-than-expected 1Q25 results (20% and 22% of our and consensus 2025 net profit estimates. The company guides for 10% revenue growth and 22-25% gross margin in 2025, with exports as its key growth driver. We expect gross margin to improve slightly in 2H25 on product reformulation, a round of ASP adjustments and cost-optimisation. The company has proposed a Rp1t share buyback from 5 Jun 25 to 5 Jun 26.
MYOR guided that the steep increase in cocoa and coffee prices is likely to continue negatively impace margins in 4Q24 and 1H25. 4Q24 margin improvement on a qoq basis is expected while margins will be soft yoy. A mixed performance was observed in export markets. In 2025, MYOR will introduce 5-10 new products. We expect 2025 NPAT to increase 11.1% yoy and 2024 NPAT to decline 7.7% yoy. Maintain HOLD with a target price of Rp2,300.
INDONESIA Update Mayora Indah (MYOR IJ/HOLD/Rp2,500/Target: Rp2,300) Margins will still be negatively affected in 4Q24 and 1H25. MALAYSIA Sector Oil & Gas PAO aligns with our view on cuts in exploration/JU rig demand, but maintenance demand remains intact. Plant turnaround may be the biggest winner, but with high execution risks in 2Q25, 2Q26 and 1Q27. SINGAPORE Sector REITs ...
GREATER CHINA Results Anhui Conch Cement (914 HK/BUY/HK$16.46/Target: HK$19.50) 1H24: Below expectations; exploring opportunities in overseas markets. CR Mixc (1209 HK/BUY/HK$23.25/Target: HK$33.70) 1H24: Results in line with surprise from special dividend. Haidilao International Holding (6862 HK/BUY/HK$12.34/Target: HK$19.60) 1H24: Core net profit up 13% yoy. Accelerated store opening pace in 2H24; dividend payout expected to remain at reasonable leve...
Consumer companies’ 2Q24 core NPAT rose 19.8% yoy. Indofood Group performed well, with core NPAT of ICBP and INDF rising 31.5% and 41.2% yoy. Consumer companies’ margins expanded thanks to a decline in wheat and skim milk powder prices. Retailers’ margins were stable, with 2Q24 NPAT declining 17.2% yoy. Boycotts on multinational companies are likely to continue. The 2H24 outlook should be similar to that of 1H24, with a bleak 2025 outlook. Maintain MARKET WEIGHT. Our picks: ACES and CMRY.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.